Perimenopause: Clinical Trials

3 trials for Perimenopause, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2

Follow Perimenopause: new trials by email Literature Review of Perimenopause trials Research Report on Perimenopause

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow
Oral Micronized Progesterone, Placebo - Perimenopause, Menstrual Cramps
Phase 3CompletedUniversity of British Columbia592015-06-012020-03-24
Acupuncture for Relieving Perimenopausal Symptoms
Acupuncture, Climen 21 Tablets - Perimenopause
Phase 2 / Phase 3CompletedChengdu University of Traditional Chinese Medicine2202013-09-012020-02-17
Perimenopausal Estrogen Replacement Therapy Study
Estradiol, Placebo - Perimenopause, Menopause
Phase 2 / Phase 3CompletedUniversity of North Carolina, Chapel Hill1722010-10-012017-08-22

Narrower conditions

Depression (1)  ·  Dysmenorrhea (1)  ·  Hot Flashes (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Menstruation Disturbances (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pelvic Pain (1)

Interventions

Progesterone (2)  ·  Acupuncture Therapy (1)  ·  Estradiol (1)  ·  estradiol valerate, cyproterone acetate drug combination (1)

Sponsors

Chengdu University of Traditional Chinese Medicine (1)  ·  University of British Columbia (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

Canada (1)  ·  China (1)  ·  United States (1)

Top investigators

Jerilynn C Prior, MD, FRCPC (1)  ·  Susan Girdler, PH.D. (1)  ·  Ying Li, MD, PhD (1)

Results publications

PMID 24886348, PMID 29322164, PMID 31838497, PMID 32706883, PMID 33288437

NIH funding

R01MH087619 (1)